生物羊膜制品置入改善宫腔粘连术后子宫内膜容受性分析

doi:10.13418/j.issn.1001-165x.2022.1.20

中国临床解剖学杂志 ›› 2022, Vol. 40 ›› Issue (1): 98-102.doi: 10.13418/j.issn.1001-165x.2022.1.20

生物羊膜制品置入改善宫腔粘连术后子宫内膜容受性分析

崔淑岭，　张英芝，　张晶，　劳佩维*

宁波大学医学院附属医院妇产科，浙江宁波 315211

收稿日期:2021-07-19 出版日期:2022-01-25 发布日期:2022-01-19
通讯作者: 劳佩维，主任医师，E-mail：lpw121@aliyun.com
作者简介:崔淑岭（1986-），女，主治医师，河北承德人，主要从事宫腔粘连术后再粘连的预防、子宫内膜异位症等继发性不孕症研究，E-mail：fycuishuling@nbu.edu.cn
基金资助:
浙江省自然科学基金（LY18H040009）

Analysis of endometrial receptivity after implantation of biological amniotic products to improve intrauterine adhesions

Cui Shuling, Zhang Yingzhi, Zhang Jing, Lao Peiwei*

Department of Obstetrics and Gynecology，The Affiliated Hospital of Medical School, Ningbo University, Ningbo 315211, China

Received:2021-07-19 Online:2022-01-25 Published:2022-01-19

摘要/Abstract

摘要： 目的　探讨生物羊膜制品用于宫腔镜下宫腔粘连分离术（transcervical resection of adhesions，TCRA）的子宫内膜容受性。方法　回顾性分析2019年11月至2020年11月本院妇产科收治并经宫腔镜检查确诊为中、重度宫腔粘连患者64例。按TCRA术后预防再粘连的方法分为实验组（术后注入几丁糖并放置生物羊膜制品）和对照组（术后注入几丁糖），各32例。使用2015年中国宫腔粘连分级评分标准诊断宫腔粘连程度。所有患者术后给予雌孕激素人工周期治疗2月，术后3月行宫腔镜复查。比较两组患者术后再粘连率以及子宫内膜厚度、子宫动脉阻力参数、妊娠结局等。结果　术后1个月实验组和对照组子宫内膜厚度分别为（5.89±0.84）mm和（4.37±0.52）mm，差异有统计学意义（t＝8.689，P<0.01）；术后2个月实验组子宫内膜厚度为（8.38±0.84）mm，对照组（7.17±1.00）mm，差异有统计学意义（t＝5.215，P<0.01）。宫腔镜复查，实验组再粘连率为6.25%，对照组为18.75%，差异有统计学意义（P<0.05）。两组子宫动脉血流参数以及妊娠率等比较均有统计学差异（P<0.05）。结论　在中、重度宫腔粘连分离术后置入生物羊膜制品，可以增加子宫内膜厚度，改善子宫血液循环，从而改善子宫内膜容受性，提高妊娠率。因此，置入生物羊膜制品可以作为临床治疗宫腔粘连有效可行的新辅助治疗手段。

关键词: 宫腔粘连, 　生物羊膜制品, 　宫腔粘连分离术, 　子宫内膜容受性

Abstract: Objective　To investigate the endometrial receptivity of biological amniotic products after hysteroscopic intrauterine adhesion separation (TCRA). Methods A retrospective analysis for clinical data of 64 cases of women who received TCRA because of medium or heavy IUA in the Affiliated Hospital of Medical School, Ningbo University from November 2019 to November 2020 was performed. The 64 cases were divided into the following two groups according to the method of TCRA postoperative readhesion prevention: an experimental group (biological amniotic products were placed after TCRA with chitosan), and a control group (chitosan was placed after TCRA). Each group was 32 cases. The Chinese Intrauterine Adhesion Grating and Scoring Standard proposed by Chinese Clinical Diagnostics Experts of Intrauterine Adhesion in 2015 was used to diagnose the degree of intrauterine adhesions. All patients received artificial cycle treatment of estrogen progesterone for 2 months. The endometrial thickness, uterine artery resistance parameters and pregnancy rate were compared between the two groups. Results One month after operation, the endometrial thickness of the experimental group and the control group were (5.89±0.84) mm and (4.37± 0.52) mm, respectively, the differences were statistically significant (T=8.689,P<0.01). Two months after operation, the endometrial thickness of the experimental group and the control group were (8.38±0.84) mm, (7.17±1.00) mm, the differences were statistically significant (t＝5.215, P<0.01). At the second hysteroscopy, the readhesion rate of the experimental group was 6.25%, and that of the control group was 18.75%, with statistical significance (P<0.05). There were statistical differences in the arterial blood flow parameters and pregnancy rate between the two groups. Conclusions The implantation of biological amniotic membrane products after the separation of moderate or severe intrauterine adhesions can increase the thickness of the endometrium and improve the blood circulation of the uterus and the receptivity of the endometrium, ultimately increase the pregnancy rate. Therefore, the implantation of biological amniotic membrane products can be an effective and feasible neoadjuvant treatment for clinical treatment of intrauterine adhesions.

Key words: Intrauterine adhesion;　Biological amniotic products;　Intrauterine adhesion separation, Endometrial receptivity

中图分类号:

崔淑岭, 张英芝, 张晶, 劳佩维. 生物羊膜制品置入改善宫腔粘连术后子宫内膜容受性分析[J]. 中国临床解剖学杂志, 2022, 40(1): 98-102.

Cui Shuling, Zhang Yingzhi, Zhang Jing, Lao Peiwei. Analysis of endometrial receptivity after implantation of biological amniotic products to improve intrauterine adhesions[J]. Chinese Journal of Clinical Anatomy, 2022, 40(1): 98-102.

参考文献

[1] Xu WZ, Zhang YX, Yang Y, et al. Effect of early second-look hysteroscopy on reproductive outcomes after hysteroscopic adhesiolysis in patients with intrauterine adhesion, a retrospective study in China[J]. Int J Surg, 2018, 50: 49-54. DOI: 10.1016/j.ijsu. 2017. 11.040.
[2] Amer MI, Abd-El-Maeboud KHI, Abdelfatah I, et al. Human amnion as a temporary biologic barrier after hysteroscopic lysis of severe intrauterine adhesions: pilot study[J]. J Minim Invasive Gynecol, 2010, 17(5): 605-611. DOI: 10.1016/j.jmig.2010.03.019.
[3] 彭雪冰, 夏恩兰. 宫腔内羊膜植入+人工周期对治疗及预防宫腔粘连的应用研究[C]// 厦门: 中华医学会第十次全国妇产科学术会议, 2012.
[4] 何全中. 羊膜移植对预防宫腔粘连电切术后宫腔再粘连的研究[J]. 中国妇幼保健, 2013,28(17): 2799-2801.DOI:10.7620/zgfybj.j.issn.1001-4411. 2013.28.52.
[5] 王欣, 段华. 羊膜制品在重度宫腔粘连治疗中的应用及疗效分析[J]. 中华妇产科杂志, 2016(1): 27-30. DOI: 10.3760/cma.j.issn.0529-567x.2016.01.007.
[6] Zheng F, Zhu B, Liu Y, et al. Meta-analysis of the use of amniotic membrane to prevent recurrence of intrauterine adhesion after hysteroscopic adhesiolysis[J]. Int J Gynecol Obstet, 2018, 143(2): 145-149. DOI: 10.1002/ijgo.12635.
[7] 中华医学会妇产科学分会. 宫腔粘连临床诊疗中国专家共识[J]. 中华妇产科杂志, 2015, 50(12): 881-887. DOI: 10.3760/cma.j.issn.0529-567x.2015.12.001.
[8] Asherman JG. Amenorrhoea traumatica (atretica)[J]. J Obstet Gynaecol Br Emp, 1948,55(1): 23-30. DOI: 10.1111/j.1471-0528.1948.tb07045.x.
[9] 朱小莉, 魏佑震. 反复流产的子宫解剖学因素[J]. 中国临床解剖学杂志, 2007, 25(6): 718-720. DOI: 10.3969/j.issn.1001-165X.2007.06.032.
[10] 池余刚. 宫腔粘连术后辅助治疗的研究进展[J]. 现代妇产科进展, 2019, 28(2): 155-157. DOI: 10.13283/j.cnki.xdfckjz.2019.02.018.
[11] Tohma YA, Esin S. A novel contributor to endometrial receptivity: endometrial microbiota[J]. Gynecol Obstet Res-Open J, 2017, 4(1): e1-e3. DOI: 10.17140/GOROJ-4-e006.
[12] 中国医师协会超声医师分会. 中国妇科超声检查指南[M]. 北京: 人民卫生出版社.
[13] 李权, 谭晓珊, 陈家仙, 等. A、C型子宫内膜种植窗期胞饮突的形态学观察[J].山东医药, 2008, 48(17): 29-30. DOI: 10.39:69/j.issn.1002-266X.2008.17.012.
[14] Basir GS, Lam TP, Chau MT, et al. Colour Doppler analysis of periimplantation utero-ovarian haemodynamics in women with excessively high oestradiol concentrations after ovarian stimulation[J]. Hum Reprod, 2001, 16 (10): 2114-2117. DOI: 10.1093/humrep/16.10.2114.
[15] 杨仁祥, 武泽. 子宫内膜容受性的研究进展[J]. 实用妇产科杂志, 2019, 35(1): 19-23. DOI: 1003-6946(2019)01-0019-05.

生物羊膜制品置入改善宫腔粘连术后子宫内膜容受性分析

Analysis of endometrial receptivity after implantation of biological amniotic products to improve intrauterine adhesions

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

Metrics

本文评价

推荐阅读 0

[1]	江剑宏, 段仁鹏, 李晓锋. 国人胆道三维重建解剖变异应用研究[J]. 中国临床解剖学杂志, 2024, 42(1): 1-4.
[2]	郭红志, 王瑜, 张加琪, 梁海彬, 马梓玮, 冯伟, 吴忧, 司子燚. 血管铸型结合CT三维模型评估先兆子痫胎盘血管结构[J]. 中国临床解剖学杂志, 2024, 42(1): 5-10.
[3]	李佳伟, 张静, 李灿然, 兰文杰, 籍庆余, 郭志勇, 张云凤, 刘启, 陈清威, 李筱贺. 蒙古族人群股骨近端解剖参数X线测量[J]. 中国临床解剖学杂志, 2024, 42(1): 11-16.
[4]	李琨, 张燕, 郭冉, 郝咪咪, 吴轩宇, 徐艺芳, 王超群, 马文童, 张灵淇, 杨宏宇, 李志军, 张少杰, 王星. 儿童及青少年枕颈角与后枕颈角数字化测量及其临床意义[J]. 中国临床解剖学杂志, 2024, 42(1): 17-20.
[5]	王兴航, 丁佳媛, 李放, 包翠芬, 阎丽菁. 人参皂苷Rg1通过抑制NLRP3炎症小体途径减轻氧糖剥夺/复供后小胶质细胞炎症反应[J]. 中国临床解剖学杂志, 2024, 42(1): 33-41.
[6]	吴研飞, 马剑雄, 卢斌, 王颖, 柏豪豪, 靳洪震, 马信龙. CT后处理技术重建CT值与终板抗压强度的相关性研究[J]. 中国临床解剖学杂志, 2024, 42(1): 71-76.
[7]	庄万强, 唐毅, 骆勇刚, 张辉. 关节镜联合胫骨高位截骨术对髌骨位置及髌股关节功能影响的早中期回顾性研究[J]. 中国临床解剖学杂志, 2024, 42(1): 77-82.
[8]	罗鹰, 窦伟誉, 吴小杭, 陈璟昆, 彭昌贵, 潘剑英 . 微创海马钢板内固定治疗跟骨骨折并发症的影响因素[J]. 中国临床解剖学杂志, 2024, 42(1): 83-88.
[9]	陈俊臣, 曹文英, 罗燕君, 何婉仪, 朱真真, 彭志强. 抽吸取栓术与抽吸结合支架取栓术治疗脑前循环栓塞疗效比较[J]. 中国临床解剖学杂志, 2024, 42(1): 89-93.
[10]	胡硕红, 郑学彬, 李富杰, 王鸿. 种植基台材料对种植体周围软硬组织影响的前瞻性临床研究[J]. 中国临床解剖学杂志, 2024, 42(1): 94-98.
[11]	林杰, 金甬, 庞清江. 胃肠道菌群与骨质疏松症关系的研究进展[J]. 中国临床解剖学杂志, 2024, 42(1): 109-111.
[12]	张悦, 蔡兴博, 张必欢, 王斌, 徐永清. 全腕关节置换术后腕关节生物力学研究进展[J]. 中国临床解剖学杂志, 2024, 42(1): 112-114.
[13]	陈仁, 杨胜波. 咬肌的解剖与临床应用研究进展[J]. 中国临床解剖学杂志, 2024, 42(1): 115-117.
[14]	徐浩铜, 徐万宇, 吴毅, 何明静, 雷秀兵, 田伏洲. 慢性胰腺炎脾门假性囊肿分类及其与SPH关系的影像学研究[J]. 中国临床解剖学杂志, 2023, 41(6): 652-656.
[15]	刘展, 陶胜忠, 卢慧鹏, 王在斌, 睢豫擘, 牛光明. MRI三维观察血管压迫神经根在原发性三叉神经痛患者和非疼痛人群中差异[J]. 中国临床解剖学杂志, 2023, 41(6): 667-674.